Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”) announced its financial results for the three months ended August 31, 2022. All amounts are stated in Canadian dollars unless otherwise indicated.
The special committee of the Company’s board of directors is continuing to explore, review and evaluate a broad range of strategic alternatives with its strategic review process. The Company’s cash position and balance sheet remain strong and the Company looks forward to finding the best path forward for all shareholders.
A copy of the Company’s financial statements for the three months ended August 31, 2022 and the related management’s discussion and analysis are available under the Company’s profile on SEDAR at www.sedar.com.
Larissa Chaikowsky has resigned as a director of the Company’s board of directors effective November 1, 2022. While the special committee of the Company’s board of directors continues to consider strategic alternatives, a replacement will not be appointed. “On behalf of the board of directors and the Company, I would like to thank Larissa for her contribution and support. Her commitment and insight were very much appreciated by the board and management. ” stated Philip Tapley, CEO and Chair of the board of directors of MINDCURE.